These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10236530)
1. The FTC's injunctive authority against false advertising of food and drugs. Mich Law Rev; 1977 Mar; 75(4):745-67. PubMed ID: 10236530 [No Abstract] [Full Text] [Related]
2. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
5. FTC's rulemaking authority under fire in courts. Congress. Am Med News; 1979 Sep; 22(37):1, 6. PubMed ID: 10243775 [No Abstract] [Full Text] [Related]
7. Update on FTC's rulemaking on KID-VID advertising. Horowitz HS J Public Health Dent; 1980; 40(1):85-7. PubMed ID: 6928497 [No Abstract] [Full Text] [Related]
8. Off label drug promotion. Body Posit; 1998 Oct; 11(10):11. PubMed ID: 11365909 [TBL] [Abstract][Full Text] [Related]
9. US Congress to consider limits on DTCA. Guthrie P CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685 [No Abstract] [Full Text] [Related]
10. US aims to tighten rules on direct-to-consumer drug ads. Vastag B Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868 [No Abstract] [Full Text] [Related]
11. The FTC's regulation of advertising. Maher AV; Fair L Food Drug Law J; 2010; 65(3):589-622. PubMed ID: 24479243 [No Abstract] [Full Text] [Related]
12. Pharmaceuticals and medical devices: FDA oversight. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
13. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557 [No Abstract] [Full Text] [Related]
14. The new drug marketing: a consumer protection perspective. Woodward D Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
15. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices. Helmanis AM Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732 [No Abstract] [Full Text] [Related]
17. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs. Patsner B Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473 [No Abstract] [Full Text] [Related]
18. The past, present, and future of direct-to-consumer prescription drug advertising. Perri M; Shinde S; Banavali R Clin Ther; 1999 Oct; 21(10):1798-811; discussion 1797. PubMed ID: 10566574 [TBL] [Abstract][Full Text] [Related]
19. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages. Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586 [No Abstract] [Full Text] [Related]
20. Regulation of cosmetics that are also drugs. Greff JA Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201 [No Abstract] [Full Text] [Related] [Next] [New Search]